In this segment, panelists discussed the various tools that are used to measure pathway adherence.
In this segment, panelists discussed the various tools that are used to measure pathway adherence.
Dr Nabhan said that short of monitoring patients' adherence to the proper pathways via electronic health records (EHR), there are not many tools that come to mind for driving adherence. He said there should always be the expectation that some patients will not be adherent.
Dr Tischler said due to variability, there may be up to 25% of patients who “fall out” of adherence. However, providers have a responsibility to determine what the cause of non-adherence is. Web portal monitoring could be 1 way to make this easier and more streamlined.
In fact, Dr Malin said that WellPoint uses a Web portal to monitor adherence. However, the tools and goals of pathways adherence can be different. Some pathways have a “single-best approach” that focuses on population health management, where other pathways can have 3-4 treatment options that might be applicable.
“I think when you’re looking at adherence rates across different pathway programs, you can’t necessarily assume that you should see the same benchmark for different programs because it may vary with how the program is designed,” said Dr Malin.
Dr Yu said he has not seen successful integration of pathways with the EHR commonly used by oncologists. The current system can cause extra work, and there is lack of efficient pathway mapping. Vendors also currently lack incentive to improve EHR systems.
Potential Spillover Effects on Traditional Medicare When Physicians Bear Medicare Advantage Risk
February 26th 2025Medicare beneficiaries treated by physicians with high levels of Medicare Advantage risk exposure had higher care quality and efficiency outcomes compared with those treated by other physicians.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Balancing Innovation and Equity in Oncology Value-Based Care: Panel Discussions
January 27th 2025Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common theme emerged: the need to balance innovation with patient-centered, equitable, and sustainable care models.
Read More